Jan 7, 2025 · Ansimar is used in the treatment and prevention of chronic obstructive pulmonary disease and asthma. Ansimar is a bronchodilator. It works by relaxing the muscles of the airways and widens airways.

Know about technical details of Ansimar like: chemical name, chemistry structure, formulation, uses, toxicity, action, side effects and more at Pharmacompass.com.

Nov 8, 2024 · Doxofylline (Ansimar) generic is an antitussive, prescribed for asthma and Chronic Obstructive Pulmonary Disease (COPD).

Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma [1] and COPD. [2] . Like theophylline, it is a xanthine derivative. [3][4] Doxophylline is used to treat chronic respiratory diseases such as asthma [1] and COPD. [2]

Jan 7, 2025 · Doxophylline is used to treat asthma, COPD and bronchospasm. Doxofylline is also used to associated treatment for these conditions: Bronchial Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Diseases. The main mechanism of …

Ansimar BRONCHODILATOR FORMULATION . Each tablet contains 200 mg Doxofylline. INDICATIONS. For the treatment of COPD, bronchial asthma and pulmonary disease with spastic bronchial component. DOSAGE . Elderly Patients: 200 mg tablet two or three times daily. Adults: 400 mg tablet two or three times daily or as prescribed by a physician. CLINICAL ...

Doxofylline, also known as Ansimar and ABC-12-3, is a novel xanthine bronchodilator. Doxofylline's mechanism of action is related to the inhibition of phosphodiesterase activities, but it appears to have decreased affinities towards adenosine A1 and A2 receptors,

Derivato xantinico, antiasmatico ad uso sistemico. INDICAZIONI TERAPEUTICHE. Affezioni polmonari con componente spastica bronchiale. Il preparato ANSIMAR è controindicato nei soggetti con ipersensibilità nota al farmaco o verso altri derivati xantinici, in caso di infarto miocardico acuto, negli stati ipotensivi e durante l' allattamento.

Dec 21, 2019 · Compresse da 400 mg: 1 compressa due/tre volte al giorno negli adulti Fiale da 100 mg: negli adulti 2 fiale per via endovenosa. somministrate in pazienti in clinostatismo e lentamente (15-20 minuti), preferibilmente diluite, in fase acuta.

Oct 18, 2023 · Ansimar è un farmaco a base del principio attivo Doxofillina, appartenente alla categoria degli Antiasmatici, derivati xantinici e nello specifico Derivati xantinici. E' commercializzato in Italia dall'azienda Jakinmed S.r.l. .